NCT02472691 2020-05-28
AZALENA
Heinrich-Heine University, Duesseldorf
Phase 2 Completed
Heinrich-Heine University, Duesseldorf
Case Comprehensive Cancer Center
Sunnybrook Health Sciences Centre
Groupe Francophone des Myelodysplasies
Arbeitsgemeinschaft medikamentoese Tumortherapie